Research Paper Notes on Diabetes :: Prevalence and Incidence

Article #1: Prevalence/Incidence Global Estimates of the Prevalence of Diabetes for 2010 and 2030 Diabetes is a disease that continues to increase worldwide. It continues to be a large problem in both developed and undeveloped countries. This article summarizes a study that focused on the future estimated number of people diagnosed with diabetes from 2010 to 2030. The findings were that the amount of people diagnosed with the disease would increase worldwide by about 1% (increasing by about 200 million more diagnosed adults ranging from ages 20-79 years old). It does not sound like much, but the number of people diagnosed with diabetes in underdeveloped countries would increase by about 69% by 2030 and the number diagnosed in developed countries would increase by about 20% by 2030. This article goes to show that the problem of diabetes is not going away anytime soon. It is a growing epidemic that continues to affect millions of people worldwide. I think that more people need to be educated about diabetes and their personal lifestyle choices that affect their health in such an immense manner. I know that it is easier said than done, but knowledge is power. And in this case, the more knowledge people have about diabetes and diabetes prevention, the more the numbers of people diagnosed with the disease will go down. Article #2: Treatment Liraglutide: Effects Beyond Glycaemic Control in Diabetes Treatment The article expresses the correlation of obesity and patients with type 2 diabetes and how the GLP-1 receptor, Liraglutide, can stimulate weight loss in these obese patients. Because of their high levels of insulin resistance, obese individuals have a greater chance of being diagnosed with Type 2 diabetes. After performing clinical trials by treating patients diagnosed with Type 2 diabetes, it was found that Liraglutide does stimulate weight loss as well as increase beta-cell function. Scientists believe that Liraglutide can decrease the number of patients diagnosed with Type 2 diabetes as well as prevent Cardio Vascular Disease. I found this article to be very interesting. I knew that obesity played a large role in the diagnosis of Type 2 diabetes, but I did not know the lengths to which scientists are trying to decrease obesity through certain hormone injections. I think that the growing obese population in the United States should adopt a healthier overall lifestyle before having to turn to hormone injections for weight loss. Even though the use of Liraglutide can lower both Type 2 diabetes and Cardio Vascular Disease, so can a healthy lifestyle.